(11) 98705-3426
TrademarkIQ íconeTrademarkIQ
Voltar para busca
Dado oficial do USPTO

CUBE MEDICAL INNOVATIONS CONCEPTUALIZE - CREATE - COMMERCIALIZE

Sabia que essa marca já está registrada no Estados Unidos?

Antes de investir em nome, identidade e divulgação, valide risco de colisão e estratégia de registro para não perder tempo nem budget.

Active USPTO registrationTipo: MistaEscritório: Estados Unidos

Snapshot rápido

CUBE MEDICAL INNOVATIONS CONCEPTUALIZE - CREATE - COMMERCIALIZE

ST13

US500000086385323

Classe

35

Pedido

86385323

Registro

5469913

Diagnóstico de risco e oportunidade

Leitura executiva para decisão de naming, protocolo e monitoramento.

Situação USPTO

Active USPTO registration

Tipo de processo

Pedido e registro

Eventos registrados

54

Atualização mais recente

28/09/2023

Tipo de marca

Mista

Classes Nice

35

Data de depósito

04/09/2014

Data de registro

15/05/2018

Data de expiração

-

Dados completos do processo

Campos estruturados da autoridade responsável e do histórico oficial.

Data da situação

28/09/2023

Última transação

28/09/2023

Escritório responsável

United States Patent and Trademark Office

Código da situação

701

Cadastro oficial

Principal Register

Fundamento do pedido

Intent to use

Primeiro uso

22/03/2018

Primeiro uso no comércio

22/03/2018

Código do desenho

3

Tipo de titular

03

Localização do titular

Colorado Springs, CO

Examinador

BHANOT, KAPIL

Unidade examinadora

L80

Localização atual

TMEG LAW OFFICE 108

Descrição da marca

The mark consists of a perspective view of a stylized cube design; wherein the cube design is comprised of three individual cubes wide by three individual cubes high by three individual cubes deep; further wherein an individual, middle row, center, blue cube is exploded from a front face of the cube design; an individual, middle row, center, yellow cube is emerging from a bottom face of the cube design; an individual, top row, center, red cube is emerging from a right face of the cube design; an individual, middle row, right, blue cube is emerging from a right face of the cube design; further wherein all other individual cubes are white and the individual cubes within the cube design are spatially separated by interstitial gray shading; and further wherein the words "CUBE MEDICAL INNOVATIONS" in all capital, black letters appear in a first row beneath the cube design, and the words "Conceptualize", "Create" and "Commercialize", separated by hyphens and in initial case, italicized black letters appear in a second row beneath the cube design.

Titulares e representantes

Titulares

Cube Medical Innovations, Inc.

Representantes

Cube Medical Innovations, Inc.

Classificação técnica

Classes Nice

Classe 35

Códigos Vienna

Sem códigos Vienna disponíveis.

Produtos e serviços

Classe 35

incubation and business development servicesproviding start-up support for medical device businesses of others; new business venture development and formation consulting services for medical device businesses

Publicações

Histórico de despachos e eventos da marca no USPTO.

54 publicações encontradas

NAS8

NOTICE OF ACCEPTANCE OF SEC. 8 - E-MAILED

28/09/2023

8.OK

REGISTERED - SEC. 8 (6-YR) ACCEPTED

28/09/2023

APRE

CASE ASSIGNED TO POST REGISTRATION PARALEGAL

28/09/2023

ES8R

TEAS SECTION 8 RECEIVED

19/05/2023

REM1

COURTESY REMINDER - SEC. 8 (6-YR) E-MAILED

15/05/2023

WOAG

WITHDRAWAL OF ATTORNEY GRANTED

24/10/2022

WOAR

TEAS WITHDRAWAL OF ATTORNEY RECEIVED

24/10/2022

ARAA

ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED

15/12/2019

REAP

TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED

15/12/2019

R.PR

REGISTERED-PRINCIPAL REGISTER

15/05/2018

SUNA

NOTICE OF ACCEPTANCE OF STATEMENT OF USE E-MAILED

11/04/2018

CNPR

ALLOWED PRINCIPAL REGISTER - SOU ACCEPTED

10/04/2018

EXRA

NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED

27/03/2018

SUPC

STATEMENT OF USE PROCESSING COMPLETE

26/03/2018

EX5G

SOU EXTENSION 5 GRANTED

26/03/2018

IUAF

USE AMENDMENT FILED

22/03/2018

EXT5

SOU EXTENSION 5 FILED

22/03/2018

EEXT

SOU TEAS EXTENSION RECEIVED

22/03/2018

EISU

TEAS STATEMENT OF USE RECEIVED

22/03/2018

EXRA

NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED

26/09/2017

EX4G

SOU EXTENSION 4 GRANTED

22/09/2017

EXT4

SOU EXTENSION 4 FILED

22/09/2017

EEXT

SOU TEAS EXTENSION RECEIVED

22/09/2017

EXRA

NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED

23/03/2017

EX3G

SOU EXTENSION 3 GRANTED

21/03/2017

EXT3

SOU EXTENSION 3 FILED

21/03/2017

EEXT

SOU TEAS EXTENSION RECEIVED

21/03/2017

EXRA

NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED

21/10/2016

EX2G

SOU EXTENSION 2 GRANTED

20/10/2016

AITU

CASE ASSIGNED TO INTENT TO USE PARALEGAL

15/10/2016

EXT2

SOU EXTENSION 2 FILED

22/09/2016

EEXT

SOU TEAS EXTENSION RECEIVED

22/09/2016

EXRA

NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED

22/03/2016

EX1G

SOU EXTENSION 1 GRANTED

18/03/2016

EXT1

SOU EXTENSION 1 FILED

18/03/2016

EEXT

SOU TEAS EXTENSION RECEIVED

18/03/2016

NOAM

NOA E-MAILED - SOU REQUIRED FROM APPLICANT

22/09/2015

NPUB

OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED

28/07/2015

PUBO

PUBLISHED FOR OPPOSITION

28/07/2015

NONP

NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED

08/07/2015

PREV

LAW OFFICE PUBLICATION REVIEW COMPLETED

25/06/2015

ALIE

ASSIGNED TO LIE

22/06/2015

CNSA

APPROVED FOR PUB - PRINCIPAL REGISTER

05/06/2015

TEME

TEAS/EMAIL CORRESPONDENCE ENTERED

28/05/2015

CRFA

CORRESPONDENCE RECEIVED IN LAW OFFICE

27/05/2015

TROA

TEAS RESPONSE TO OFFICE ACTION RECEIVED

27/05/2015

TCCA

TEAS CHANGE OF CORRESPONDENCE RECEIVED

27/05/2015

GNRN

NOTIFICATION OF NON-FINAL ACTION E-MAILED

18/12/2014

GNRT

NON-FINAL ACTION E-MAILED

18/12/2014

CNRT

NON-FINAL ACTION WRITTEN

18/12/2014

DOCK

ASSIGNED TO EXAMINER

16/12/2014

MDSC

NOTICE OF DESIGN SEARCH CODE E-MAILED

16/09/2014

NWOS

NEW APPLICATION OFFICE SUPPLIED DATA ENTERED

15/09/2014

NWAP

NEW APPLICATION ENTERED

08/09/2014

Proteção contínua da sua marca

Seja avisado a cada novo depósito que ameace CUBE MEDICAL INNOVATIONS CONCEPTUALIZE - CREATE - COMMERCIALIZE ou a sua marca.

Vigilância profissional por 24 meses: monitoramos o USPTO por você e alertamos a tempo de você se opor — antes que o conflito vire prejuízo.